In vivo metabolism of the vitamin D analog, 22-oxacalcitriol: Evidence for side-chain truncation and 17-hydroxylation

Journal of Steroid Biochemistry and Molecular Biology

Volumn 66, Issue 5-6, 1998, Pages 281-293

  Ishigai, Masaki ^a   Arai, Shinichi ^a   Ishitani, Yoshihiko ^a   Kumaki, Kenji ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; CALCITRIOL DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM METABOLISM; DRUG METABOLISM; HYDROXYLATION; MALE; NONHUMAN; OXIDATION; RAT; VITAMIN D METABOLISM;

ANIMALS; CALCITRIOL; HYDROXYLATION; MALE; MODELS, CHEMICAL; RATS;

EID: 0031757992     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(98)00061-2     Document Type: Article

References (34)

1. 3. Proc. Natl. Acad. Sci. U.S.A. 78 (1981) 4990-4994.
2. Osterm V. K. and Deluka H. F., The vitamin D-induced differentiation of HL-60 cells: structural requirements. Steroids 49 (1987) 73-102.
3. Kubodera N., Miyamoto K., Akiyama M., Matsumoto M. and Mori T., Synthetic studies of vitamin D analogues. IX. Synthesis and differentiation-inducing activity of 1α,25-dihydroxy-23-oxa-, thia- and azavitamin D3. Chem. Pharm. Bull. 39 (1991) 3221-3224.
4. 3 analogues. Chem. Pharm. Bull. 40 (1992) 1494-1499.
5. Brown, A. J., Dusso, A. and Raisz, L. G., Vitamin D. Gene Regulation, Structure-Function Analysis and Clinical Application, eds. A. W. Norman, R. Bouillon, M. Thomasset. Walter de Gruyter, Berlin and New York, 1991, pp. 289-297.
6. Jones G. and Calverley M. J., A dialogue on analogues newer vitamin-D drugs for use in bone disease, psoriasis, and cancer. Trends Endocrinol. Metab. 3 (1993) 297-303.
7. Murayama E., Miyamoto K., Kubodera N., Mori T. and Matsunaga I., Synthetic studies of vitamin D3 analogues. VIII. Synthesis of 22-oxavitamin D3 analogues. Chem. Pharm. Bull. 34 (1986) 4410-4413.
8. Abe J., Morikawa M., Miyamoto K., Kaiho S., Fukushima M., Miyaura C., Abe E., Suda T. and Nishii Y., Synthetic analogues of vitamin D3 with an oxygen atom in the side chain skeleton. FEBS Lett. 226 (1987) 58-62.
9. 3, is a potent modulator of in vitro immunoregulating activity without inducing hypercalcemia in mice. Endocrinology 124 (1989) 2645-2647.
10. Brown A. J., Ritter C. R., Fench J. L., Morrissey J., Martin K. J., Murayama E., Nishii Y. and Slatopolsky E., The noncalcemic analogue of vitamin D, 22-oxacalcitriol, suppresses parathyroid hormone synthesis and secretion. J. Clin. Invest. 84 (1989) 728-732.
11. 3, on bone mineral metabolism in normal male rats. Calcif. Tissue Int. 50 (1992) 521-523.
12. Brown A. J., Berkoben M., Ritter C., Kubodera N., Nishii Y. and Slatpolsky E., Metabolism of 22-oxacalcitriol by a vitamin D-inducible pathway in cultured parathyroid cells. Biochem. Biophys. Res. Commun. 147 (1992) 565-571.
13. Masuda S., Byford V., Kremer R., Makin H. L. J., Kubodera N., Nishii Y., Okazaki A., Okano T., Kobayashi T. and Jones G., In vitro metabolism of the vitamin D analog, 22-oxacalcitriol, using cultured osteosarcoma, hepatoma and keratinocyte cell lines. J. Biol. Chem. 271 (1996) 8700-8708.
14. Kobayashi, T., Okano, T., Tsugawa, N., Masuda, S., Takeuchi, A. and Nishii, Y., Calcium-regulation hormone. II. Calcium transport, bone metabolism and new drugs. In Contrib. Nephrol, ed. H. Morii. Basel Karger, Switzerland, 1991, pp. 129-133.
15. 3, in rats. J. Biochem. 115 (1994) 373-380.
16. 3. Bioorg. Med. Chem. Lett. 4 (1994) 753-756.
17. 3. Chem. Phram. Bull. 44 (1996) 2280-2286.
18. 3. J. Labeled Comp. Radiopharm. 36 (1995) 645-654.
19. 3 and related compounds. J. Chromatogr. B 704 (1997) 11-17.
20. 3. Anal. Chem. 37 (1965) 631-636.
21. Miyazaki H., Ishibashi M., Itoh M. and Yamashita K., Diethylsilyl ether and diethylsiliconide derivatives in gas chromatography mass spectrometry of hydroxylated steroids. Biomed. Mass Spectrom. 11 (8) (1984) 377-382.
22. Nakata H., Ishibashi M., Itoh M. and Miyazaki H., Diethylhydrogensilyl cyclic diethylsilylene derivatives in gas chromatography/mass spectrometry of hydroxylated steroids. Org. Mass Spectrom. 22 (1987) 23-29.
23. Ishibashi M., Itoh M., Yamashita K., Miyazaki H. and Nakata H., Diethylhydrogensilyl cyclic diethylsilylene derivatives in gas chromatography-mass spectrometry of hydroxylated steroids. II. Chem. Pharm. Bull. 34 (1986) 3298-3305.
24. Ishibashi M., Irie T. and Miyazaki H., Diethylhydrogensilyl-cyclic diethylsililene derivatives in the gas chromatographymass spectrometry of hydroxylated steroids. IV. Hydrocortizone. J. Chromatogr. 399 (1987) 197-206.
25. 3-treated bovine. Arch. Biochem. Biophys. 213 (1982) 163-168.
26. 3. Biochemistry 20 (1981) 6230-6235.
27. 3. Biochemistry 23 (1984) 1473-1478.
28. Lohnes D. and Jones G., Side chain metabolism of vitamin D3 in osteosarcoma cell line UMR-106. J. Biol. Chem. 262 (1987) 14394-14401.
29. Henderson J., Sebag M., Rhim J., Goltzman D. and Kremer R., Dysregulation of parathyroid hormone-like peptide expression and secretionin a keratinocyte model of tumor progression. Cancer Res. 51 (1991) 6521-6528.
30. Masuda S., Strugnell S., Calverley M., Makin H. L. J., Kremer R. and Jones G., In vitro metabolism of the anti-psoriatic vitamin D analog, capcipotriol, in two cultured human keratinocyte models. J. Biol Chem. 269 (1994) 4794-4803.
31. Matsumoto K., Mahajan D. K. and Samuels L. T., The influence of progesterone on the conversion of 17-hydroxypro-gesterone to testosterone in the mouse testis. Endocrinology 94 (1974) 808-814.
32. Nakajin S., Shimoda M., Haniu M., Shivery J. E. and Hall P. F., C21 steroids side chain cleavage enzyme from porcine adrenal microsomes. J. Biol. Chem. 259 (1984) 3971-3976.
33. Zuber M. X., Shimpson E. R. and Waterman M. R., Expression of bovine 17α-hydroxylase cytochrome P-450 cDNA in non-steroidgenic (Cos 1) cells. Science 234 (1986) 1258-1261.
34. Imai T., Globerman H., Gerner J. M., Kagawa N. and Waterman M. R., Expression and purification of functional human 17α-hydroxylase/17,20-lyase (P450cl7) in Escherichia coli. J. Biol. Chem. 268 (1993) 19681-19689.